KN
Klotho Neurosciences, Inc.
🇺🇸XNAS.KLTOUnited StatesHealthcare
$0.52USDup +0.01 (+1.96%)OpenDelayed3:29 PM
Price$0.52+0.01 (+1.96%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US49876K1034
- CUSIP
- 49876K103
Company
- Employees
- 3
- Headquarters
- Omaha, United States
- Website
- https://klothoneuro.com
- CEO
- Dr. Joseph A. Sinkule Pharm.D.
Market
- Shares outstanding
- 108.1M
- Market cap
- $37.72M
Highlights
- Market cap
- $37.72M
- EPS LTM
- -$0.10calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -4.98calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$11.29M-168.2%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$5.55M-201.42%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.